These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Combined GM-CSF and G-CSF administration mobilizes CD4 Sasaki K; Wang YC; Lu L; Hughes J; Vujevich V; Thomson AW; Ezzelarab MB Am J Transplant; 2020 Jun; 20(6):1691-1702. PubMed ID: 31883190 [TBL] [Abstract][Full Text] [Related]
8. Hematopoietic stem/progenitor cell differentiation towards myeloid lineage is modulated by LIGHT/LIGHT receptor signaling. Chen W; Lv X; Liu C; Chen R; Liu J; Dai H; Zou GM J Cell Physiol; 2018 Feb; 233(2):1095-1103. PubMed ID: 28422285 [TBL] [Abstract][Full Text] [Related]
9. Stimulation of granulopoiesis by transforming growth factor beta: synergy with granulocyte/macrophage-colony-stimulating factor. Keller JR; Jacobsen SE; Sill KT; Ellingsworth LR; Ruscetti FW Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7190-4. PubMed ID: 1831268 [TBL] [Abstract][Full Text] [Related]
10. Human granulocyte-macrophage colony-stimulating factor (hGM-CSF)-dependent in vitro and in vivo proliferation and differentiation of all hematopoietic progenitor cells in hGM-CSF receptor transgenic mice. Nishijima I; Watanabe S; Nakahata T; Arai K J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 2):S79-86. PubMed ID: 9440551 [TBL] [Abstract][Full Text] [Related]
11. Flt3 ligand synergizes with granulocyte-macrophage colony-stimulating factor or granulocyte colony-stimulating factor to mobilize hematopoietic progenitor cells into the peripheral blood of mice. Brasel K; McKenna HJ; Charrier K; Morrissey PJ; Williams DE; Lyman SD Blood; 1997 Nov; 90(9):3781-8. PubMed ID: 9345066 [TBL] [Abstract][Full Text] [Related]
12. Distinct and overlapping direct effects of macrophage inflammatory protein-1 alpha and transforming growth factor beta on hematopoietic progenitor/stem cell growth. Keller JR; Bartelmez SH; Sitnicka E; Ruscetti FW; Ortiz M; Gooya JM; Jacobsen SE Blood; 1994 Oct; 84(7):2175-81. PubMed ID: 7919333 [TBL] [Abstract][Full Text] [Related]
13. Reactive oxygen species mediate stem cell factor synergy with granulocyte/macrophage colony-stimulating factor in a subpopulation of primitive murine hematopoietic progenitor cells. Pyatt DW; Stillman WS; Irons RD Mol Pharmacol; 1996 Jun; 49(6):1097-1103. PubMed ID: 8649349 [TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta trans-modulates the expression of colony stimulating factor receptors on murine hematopoietic progenitor cell lines. Jacobsen SE; Ruscetti FW; Dubois CM; Lee J; Boone TC; Keller JR Blood; 1991 Apr; 77(8):1706-16. PubMed ID: 1707695 [TBL] [Abstract][Full Text] [Related]
15. Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells. Gaudreau S; Guindi C; Ménard M; Besin G; Dupuis G; Amrani A J Immunol; 2007 Sep; 179(6):3638-47. PubMed ID: 17785799 [TBL] [Abstract][Full Text] [Related]
16. Mobilization of hematopoietic progenitors from normal donors using the combination of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor results in fewer plasmacytoid dendritic cells in the graft and enhanced donor T cell engraftment with Th1 polarization: results from a randomized clinical trial. Lonial S; Akhtari M; Kaufman J; Torre C; Lechowicz MJ; Flowers C; Sinha R; Khoury HJ; Langston AA; Waller EK Biol Blood Marrow Transplant; 2013 Mar; 19(3):460-7. PubMed ID: 23201472 [TBL] [Abstract][Full Text] [Related]
17. Selective in vivo mobilization with granulocyte macrophage colony-stimulating factor (GM-CSF)/granulocyte-CSF as compared to G-CSF alone of dendritic cell progenitors from peripheral blood progenitor cells in patients with advanced breast cancer undergoing autologous transplantation. Avigan D; Wu Z; Gong J; Joyce R; Levine J; Elias A; Richardson P; Milano J; Kennedy L; Anderson K; Kufe D Clin Cancer Res; 1999 Oct; 5(10):2735-41. PubMed ID: 10537336 [TBL] [Abstract][Full Text] [Related]
18. A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells. To LB; Haylock DN; Dowse T; Simmons PJ; Trimboli S; Ashman LK; Juttner CA Blood; 1994 Nov; 84(9):2930-9. PubMed ID: 7524760 [TBL] [Abstract][Full Text] [Related]
19. Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin. Brugger W; Möcklin W; Heimfeld S; Berenson RJ; Mertelsmann R; Kanz L Blood; 1993 May; 81(10):2579-84. PubMed ID: 7683923 [TBL] [Abstract][Full Text] [Related]
20. Attenuated hematopoietic response to granulocyte-macrophage colony-stimulating factor in patients with acquired pulmonary alveolar proteinosis. Seymour JF; Begley CG; Dirksen U; Presneill JJ; Nicola NA; Moore PE; Schoch OD; van Asperen P; Roth B; Burdach S; Dunn AR Blood; 1998 Oct; 92(8):2657-67. PubMed ID: 9763547 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]